12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 healthcare stocks during Thursday's after-market session. Notable gainers include Scorpius Holdings (AMEX:SCPX), Kintara Therapeutics (NASDAQ:KTRA), and Doximity (NYSE:DOCS). Significant losers include TFF Pharmaceuticals (NASDAQ:TFFP), OptiNose (NASDAQ:OPTN), and Turnstone Biologics (NASDAQ:TSBX).
May 16, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Doximity stock rose 11.4% to $26.45, with a market cap of $4.9 billion. Q4 earnings report was released today.
The stock's rise following the Q4 earnings report suggests strong performance, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Kintara Therapeutics stock increased by 19.22% to $0.17, with a market cap of $6.7 million. Q3 earnings were released 2 days ago.
The stock's rise following the Q3 earnings report indicates positive market reaction, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Scorpius Holdings shares rose 20.9% to $0.12, with a market cap of $4.3 million.
The significant price increase suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
OptiNose stock decreased by 9.24% to $1.18, with a market cap of $133.3 million. Q1 earnings were released 2 days ago.
The stock's decline following the Q1 earnings report suggests negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
TFF Pharmaceuticals stock decreased by 11.5% to $2.0, with a market cap of $6.1 million. Q1 earnings were released 2 days ago.
The stock's decline following the Q1 earnings report indicates negative market reaction, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Turnstone Biologics stock fell 6.23% to $2.56, with a market cap of $59.2 million. Q1 earnings were released 3 days ago.
The stock's decline following the Q1 earnings report indicates negative market reaction, likely leading to short-term losses.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75